Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Trial of Rifampin and Azithromycin for the Treatment of River Blindness

This study has been completed.
Universidad del Valle, Guatemala
University of Alabama at Birmingham
Information provided by:
Centers for Disease Control and Prevention Identifier:
First received: August 4, 2005
Last updated: August 23, 2005
Last verified: August 2005
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: May 2004
  Estimated Primary Completion Date: No date given